glp-1 lean mass loss Glucagon-like peptide-1 receptor agonists and muscle effects GLP-1 medications don't just shrink
Description
US retailers that move early to tailor product ranges and merchandise their shelves targeting GLP-1 users may be better positioned to protect share as eating behaviors change. GlobalData projects that the GLP-1 pill market will grow from $3.2 billion in 2025 to $34.3 billion in 2031, with an annual CAGR of 48.4% over the six-year period
2021;11:e047396
Report adverse events
HGP is decreased in Dpp4 hep/ mice but not mice with deletion of Dpp4 from Tie2 + endothelial cells via GLP-1 and GIP-dependent pathways
J Mol Histol
